Thomas Olivecrona
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Biochemistry top 0.05%
- Lipid metabolism and biosynthesis
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 99
- Diabetes Management and Research 31
- Biochemistry 43
- Lipid metabolism and biosynthesis 42
- Co-authors
- Gunilla Bengtsson-OlivecronaGunilla BengtssonGunilla OlivecronaTorbjörn EgelrudFredrik KarpeS EisenbergHenrik SembMagnus Hultin
- Journals
- Journal of Lipid Research (22 papers)Journal of Biological Chemistry (14 papers)Biochemical Journal (13 papers)European Journal of Biochemistry (10 papers)FEBS Letters (10 papers)
- Partner nations
- SwedenUnited StatesIsrael
In The Last Decade
Thomas Olivecrona
237 papers receiving 11.6k citations
Peers
Comparison fields: 5 of 128
- Endocrinology, Diabetes and Metabolism 5.7k
- Biochemistry 2.0k
- Cardiology and Cardiovascular Medicine 4.7k
- Nutrition and Dietetics 1.6k
- Cancer Research 1.5k
Countries citing papers authored by Thomas Olivecrona
This map shows the geographic impact of Thomas Olivecrona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Olivecrona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Olivecrona more than expected).
Fields of papers citing papers by Thomas Olivecrona
This network shows the impact of papers produced by Thomas Olivecrona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Olivecrona. The network helps show where Thomas Olivecrona may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Olivecrona, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 96 | |
| 2 | 2005 | 3 | |
| 3 | 2004 | 37 | |
| 4 | 2003 | 46 | |
| 5 | 2002 | 67 | |
| 6 | 2001 | 76 | |
| 7 | 1998 | 2 | |
| 8 | 1997 | 44 | |
| 9 | 1995 | 16 | |
| 10 | 1993 | 210 | |
| 11 | 1993 | 8 | |
| 12 | 1992 | 216 | |
| 13 | 1992 | 27 | |
| 14 | 1991 | 22 | |
| 15 | 1990 | 6 | |
| 16 | 1990 | 39 | |
| 17 | 1987 | 26 | |
| 18 | Very low density lipoprotein. Dissociation of apolipoprotein C during lipoprotein lipase induced lipolysis. | 1976 | 68 |
| 19 | Serum-stimulated lipases (lipoprotein lipases). Immunological crossreaction between the bovine and the human enzymes. | 1975 | 82 |
| 20 | 1970 | 17 |
About Thomas Olivecrona
Thomas Olivecrona is a scholar working on Endocrinology, Diabetes and Metabolism, Biochemistry, Cardiology and Cardiovascular Medicine, Clinical Biochemistry and Cell Biology, having authored 237 papers that have together received 12.1k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (99 papers), Lipid metabolism and disorders (91 papers), Lipid metabolism and biosynthesis (42 papers), Diabetes and associated disorders (33 papers), Diabetes Management and Research (31 papers), Metabolism and Genetic Disorders (25 papers), Muscle metabolism and nutrition (22 papers) and Cancer, Lipids, and Metabolism (22 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (5.7k citations), Biochemistry (2.0k citations), Cardiology and Cardiovascular Medicine (4.7k citations), Nutrition and Dietetics (1.6k citations) and Cancer Research (1.5k citations). Thomas Olivecrona has collaborated with scholars based in Sweden, United States and Israel. Frequent co-authors include Gunilla Bengtsson-Olivecrona, Gunilla Bengtsson, Gunilla Olivecrona, Torbjörn Egelrud, Fredrik Karpe, S Eisenberg, Henrik Semb, Magnus Hultin, Richard J. Deckelbaum and Olle Hernell. Their work appears in journals such as Journal of Lipid Research, Journal of Biological Chemistry, Biochemical Journal, European Journal of Biochemistry and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.